• Lexaria Bioscience continues to advance the effectiveness of its proprietary DehydraTECH technology, a formulation that teams with drug substances such as nicotine and cannabidiol to quickly carry those drugs into a user’s blood stream
• Recent concerns about the safety of vape products and ongoing concerns about the safety of tobacco are opening doors to Lexaria’s edible technology
• Newly legalized cannabis-infused edibles began hitting store shelves nationwide in Canada last month, presenting Lexaria with new potential licensing outlets for its increasingly effective products

If 2019 was the year when vape users discovered the potential perils of using untested off-brand products, 2020 may well be the year when vape users share the common woe of struggling to beat an addiction.

The U.S. Centers for Disease Control and Prevention (CDC) reported at year’s end that 2,561 people had been hospitalized with the vape-related lung illness now known as ‘e-cigarette or vaping product use-associated lung injury’ (EVALI) as of December 27, that the illness had afflicted every U.S. state and two territories, and that 55 EVALI-related deaths had been confirmed in 27 states and the District of Columbia, with the incidence of new cases in decline (http://ibn.fm/mh8Ga).

With the advent of the new year, anti-youth vaping advocacy group Truth Initiative reported (http://ibn.fm/ZmCUn) a survey that showed “nearly half of young people are looking to quit vaping as their New Year’s resolution.” Many parents find themselves fighting back fears of the potential outcomes as they see their children drawn into addictive behaviors (http://ibn.fm/XooYb).

Oral drug product innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a company dedicated to the concept that there are better alternative methods for drug substance use than inhalation. The British Columbia-based bio-delivery technology developer patented its DehydraTECH™ oral drug delivery technology and has been continuing to advance its ability to pair the IP with substances such as nicotine and cannabidiol (CBD) for access to users’ bloodstreams at rapid rates comparable to the speed of acquisition by inhalation.

Swallowed medications have historically been slower to provide effective action than inhaled ones, leading substance users looking for a quick fix to lean toward the latter. But the deleterious and deadly consequences of smoking tobacco products have been publicly acknowledged for decades, though hardly stemming the tide of nicotine addiction as one generation succeeds another.

The continued preference for the rapid delivery of inhaled drug substances has led many researchers to seek alternatives beyond deterrence campaigns. DehydraTECH’s newest formulation was recently shown to deliver to deliver 811 percent more CBD into the bloodstream than generic industry control formulations, nearly doubling the capacity of existing DehydraTECH technology. It was additionally shown to deliver 1,937 percent more CBD across the blood-brain barrier into brain tissue than generic industry control formulations and 487 percent more than the original DehydraTECH technology (http://ibn.fm/YEn9J).

The blood-brain barrier is a natural biological system of blood vessels and endothelial cells that bar nearly all small-molecule drugs from accessing the brain’s central nervous system hierarchy and finding the ability to defeat it has been a primary concern for medical product developers.

The potential applications of Lexaria’s technology are many. Perhaps most noticeable at the moment is the uses arising from the legalization of cannabis-infused food on a national basis in Canada, with the first products in store shelves as of last month (http://ibn.fm/k0GHu), but the technology also creates the potential for vape makers to offer non-inhaled products to shore up their marketing.

The company has begun licensing its technology to a variety of other producers in the cannabis and tobacco spaces. Lexaria’s licensed in-house research laboratory and its IP portfolio have developed 16 patents with over 60 patents pending worldwide.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

Do you struggle to get a good night’s sleep? It is important that you do everything possible to change that since inadequate sleep can lead to all sorts of health problems, some of which can be quite serious. Using No Borders Naturals ZZZZ’s Sleep CBD Gummies for better sleep can be highly beneficial, especially for those with insomnia.

It All Starts With Understanding CBD

Cannabidiol (CBD) interacts with the body’s endocannabinoid system, which plays a vital role in staying healthy as a whole. This is a completely different chemical compound than THC, so it doesn’t have any psychoactive effects (It won’t get you “high”).

While researchers still don’t fully understand why CBD helps with sleep, there is a lot of convincing research out there. With all of the potential health benefits of consuming cannabidiol, it should come as no surprise that better sleep is on that list.

Why is Proper Sleep so Important?

The overall quality of your sleep each night can have a huge impact on your health. This can be a positive or negative impact, depending on your sleep habits. Poor sleep has been tied to obesity, high blood pressure and other major health problems. Let’s be honest, no one is more cheerful, more engaged or more productive after a poor night’s rest. No Borders Inc. (OTC: NBDR) has shared its ZZZZ’s Sleep Gummies (http://ibn.fm/ugtCh) with Americans from sea to shining sea, and you can try them for FREE!

Treatment for Anxiety and Depression

There is a good amount of scientific research to suggest that CBD can help with managing anxiety, stress and depression. These are all things that can cause problems with the ability to get enough sleep each night. In fact, one study that came out in 2019 found that CBD has the potential to reduce anxiety while promoting better quality sleep.

The relaxed mental and physical state that can be achieved with CBD will make it easier to fall asleep and stay asleep, resulting in a more satisfying night’s rest.

Even those with PTSD could benefit from cannabidiol as a way of getting to sleep easier. Research data published in 2019 found that participants with post-traumatic stress disorder experienced reduced anxiety related to their condition with daily CBD consumption.

Easing Discomfort for Better Sleep

Another reason that CBD can be so helpful for sleep issues is that it can reduce discomfort caused by all sorts of conditions. Those who have arthritis or muscle aches can find it difficult to get a good night’s sleep on a regular basis. No Borders Naturals is proud to offer the highest quality Muscle & Joint Balm (http://ibn.fm/zy65V), as well as our world renowned CBD Body Lotion (http://ibn.fm/llf6B), as best in class topicals to help with those cranky joints and aching muscles!

Cannabidiol has been shown to significantly reduce inflammation in the body, which in turn can make getting to sleep much easier. The less discomfort you have to contend with, the better your chances are of sleeping soundly through the night.

This is actually the reason why a lot of professional athletes are taking CBD. It helps with their muscle aches while also letting them get plenty of sleep to maintain high energy levels.

Deeper Sleep

Some people who take certain medications or have PTSD can experience vivid nightmares that limit deep sleep, which is necessary for maintaining one’s overall health. A study from 2014 involving four people with Parkinson’s disease found that CBD can promote deep sleep.

Those who suffer from REM sleep behavior disorder or RBD have a very difficult time getting a good night’s sleep. Many people who have this condition experience nightmares on a regular basis, which can be mentally and physically taxing.

CBD Dosage for Better Sleep

The CBD dosage that you will need to start getting better quality sleep depends almost entirely on why you are having this problem to begin with. Some people will require a higher dosage than others, depending on the cause.

Those who have PTSD or problems with severe arthritis will likely need to take higher milligrams daily. This is largely a matter of trial and error, which may be frustrating but is necessary for many people and not hard at all to do.

How to Use CBD for Sleep Problems

There are a number of ways to use CBD to achieve better sleep results on a daily basis. It comes in a variety of forms that consumers should really be aware of before shopping around for anything in particular.

CBD oil tinctures can provide deeper and more restful sleep by reducing physical discomfort, stress, anxiety and even depression. No Borders Naturals Light Mint Hemp Seed CBD Oil Tincture (http://ibn.fm/tU5bN) can help an individual become healthier in numerous ways. It has a whopping 500 milligrams of high-quality, THC-free CBD in each bottle.

There are a lot of CBD edibles available for purchase as well. No Borders Naturals (http://ibn.fm/UHvq5) also offers many of these products including gummy candies infused with cannabidiol to provide relaxing results. No Borders Naturals also carries Vegan CBD Sleepytime Gummies (http://ibn.fm/ILiAk) for those who are on a restrictive diet.

Final Thoughts

When trying to get enough sleep each night, it is important to explore the vast array of options available. CBD offers a completely natural and often effective means of getting adequate rest each night. Numerous scientific studies have shown that cannabidiol may help people with sleep problems. It can reduce physical and mental discomfort to make falling asleep easier. When it comes to CBD for insomnia benefits, No Borders believes consumers will definitely get their money’s worth.

For more information, visit the company’s website at www.NBDR.co

NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://ibn.fm/NBDR

• SING providing a rich, diversified holding base while creating new branded products
• Company continues to see month-over-month growth, realizing opportunity in solar industry
• New 1606 Original Hemp Cigarette receives phenomenal response at MJ Business Conference

SinglePoint Inc. (OTCQB: SING) is seeing continued impressive growth through its recent acquisitions and ventures into the solar and industrial hemp spaces. SING president Wil Ralston shared on “MoneyTV” with Donald Baillargeon that business is continuing as usual, which means more impressive growth and opportunity as SING heads into the new year.

During the interview, Ralston discussed the strengths of the company, which he’s touched on in previous interviews (http://ibn.fm/eaaqh), spurring Baillargeon to chuckle, saying it sounded like “more of the same.” In the past six months, DirectSolar has shown constant, sustainable growth and promise. “More of the same” means the completion of SinglePoint’s largest quarter ever – more than 50 agents working the phones and a partnership with over 40 schools in Texas.

“We’ve taken a lot of swings with some acquisitions,” Ralston stated in the interview. “DirectSolar… has paid off, and it’s really doing a great deal for us. Exciting to have acquired DirectSolar and watching the growth path and how tightly that ship is run over there. It’s really something else. We’re excited to keep showing the shareholders and everyone else out there just how big this solar play is going to be.”

SING took another swing recently when the company released 1606 Original Hemp, a new hemp cigarette, at the 2019 MJ Business Conference (http://ibn.fm/LDe4L). Response to the new product at the show exceeded the SinglePoint’s expectations.

“The most surprising to us was just the number of individuals that were truly excited about this product and [had] never seen anything like it before,” continued Ralston, who noted that attendees were returning to the SING booth on day two and three to let company representatives know how much they enjoyed the 1606 Original Hemp Cigarette experience. Ralston is confident that SinglePoint will be receiving additional orders from stores and distributors in the near future.

This conference attendee excitement proved to be a great indicator for the product’s market viscosity, as SING received its first major 1606 Original Hemp order: approximately 5,000 packs from one distributor. Ralston noted that the company is following up with attendees, selling to additional distributors and working to establish 1606 Original Hemp as the premier hemp cigarette brand in the industry hemp market, which is projected to reach $26.6 billion by 2025 (http://ibn.fm/LKz6V).

SinglePoint provides investors with the opportunity to make investments across a wide range of assets that currently include but are not limited to solar energy, hemp, mobile-payment applications and more. SING is leveraging technology expertise into emerging opportunities. By building a portfolio in undervalued companies, the company is able to provide a rich, diversified holding base and create branded products.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• No Borders Inc.’s subsidiary No Borders Labs has launched a blockchain data security platform called CBD Lab Chain to provide cannabis industry participants peace of mind regarding the quality of cannabidiol products
• CBD Lab Chain utilizes Ethereum blockchain technology to provide consumers with supply chain transparency as they contemplate potential purchases
• The technology allows consumers to scan a QR code or a batch number on a product label that will allow consumers to see the product’s Lab Test (COA) history recorded permanently and immutably on distributed ledger (blockchain) technology

Nearly 40 years ago, a pre-digital era hacker generated alarm and panic by adding poison to store shelf Tylenol capsules and repackaging the medication so that the tampering wasn’t evident (http://ibn.fm/zL9Nl). The deaths that resulted from the hack drove innovation that has since made tamper-resistant bottle technologies standard in consumer markets.

Blockchain is becoming the 21st century iteration of tamper-proof technology, and tech solutions provider No Borders Inc. (OTC: NBDR) is one company in the industry that is working to establish confidence-building supplier-to-consumer protocols that make it far more difficult for malicious individuals to interfere with the production chain without detection, and for unintended taints by legitimate operators to remain untraceable.

No Borders is a multifaceted brand development and marketing business using its new blockchain technology platform, CBD LabChain, to protect consumers and securely inform them of the supply chain safety of cannabidiol (CBD) products which are potentially susceptible to chemical taints, inordinate tetrahydrocannabinol (THC) drug levels and incorrect CBD quality claims. The technology is currently used to safeguard CBD products developed by another subsidiary, No Borders Naturals, but has since become a potential revenue stream through sales to outside CBD retailers (http://ibn.fm/I1Nc0).

Blockchain uses a series of digital “blocks” in sequence as electronic signed receipts for every event that occurs in a transaction or chain of transactions involving a product. No Borders Labs’ CBD LabChain anticipates revenue from its technology through fees from companies dedicated to demonstrating the transparency of their product chain through lab test results that occur along the plant-to-product shelf route to the consumer.

The innovation is not occurring in a vacuum. Hemp Magazine published a recent article that noted the criminal charge and jail time a traveling CBD consumer incurred in New Mexico after her CBD bottle was found to contain too much THC under state law, contrary to her purposes (http://ibn.fm/HuSTi). In Nebraska, a family nearing the harvest of its CBD-intensive hemp crop was forced to destroy the entire crop and suffer an expensive loss after hundreds of hours of labor because regulators found the THC levels had been allowed to grow too high (http://ibn.fm/NCUGp).

An increasing number of companies are investigating the potential of blockchain to provide peace of mind and self-realization to their customers, as evidenced by the announcement by America’s second-largest health insurance company, Anthem, that it is pilot testing blockchain tech that will allow patients to securely access their medical data and share it with medical providers of their choice. The technology ensures minimal risk of sensitive medical information falling unintended into the hands of another person.

According to a recent Forbes article, company officials state all 40 million Anthem members will have access to the blockchain feature in the next two to three years (http://ibn.fm/Ue77r). The pilot program allows users to open a smartphone app, scan a QR code and instantly provide medical personnel access to their health records temporarily, with the ability to revoke access as soon as an appointment is over.

The insurer also expects to eventually use the technology to process insurance claims and coordinate benefits faster.

No Borders also uses QR code tech in its application to check the history of a product label without altering that history. The company anticipates that federal regulators would also be able to use the technology in the same way, granting an added measure of consumer assurances.

For more information, visit the company’s website at www.NBDR.co

NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://ibn.fm/NBDR

• 3D-printed weight-optimized and flow-optimized parts significantly improve the performance of aircraft and rockets
• Global aerospace 3D-printing market estimated at $1.4 billion in 2018, projected to reach $6.8 billion by 2026
• Sigma Labs’ breakthrough quality-assurance solution PrintRite3D® set to revolutionize 3D-printing industry, enabling it to grow globally

Sigma Labs Inc. (NASDAQ: SGLB) is set to exploit the tremendous aerospace 3D-printing-market growth potential with its revolutionary in-process, quality-assurance technology. This technology is poised to help the industry scale a critical hurdle: ensuring effective and efficient quality in real time.

The global aerospace 3D-printing market was estimated at $1.4 billion in 2018, projected to reach $6.8 billion by 2026 with an expected CAGR in excess of 22% during the forecast period. The airline and spacecraft segment is expected to lead the aerospace 3D-printing market due to the need for low-volume, low-weight parts that can be manufactured using 3D-printing technologies, which reduces supply chain constraints, minimizes warehouse space and lowers waste materials compared to traditional manufacturing processes (http://ibn.fm/oXjCV).

As the industry is challenged by environmental restrictions, high manufacturing cost and a competitive market environment, 3D metal components manufacturing offers a unique solution to help overcome much of these challenges.

Weight is considered the most important feature in the design and development of an aircraft because of its tremendous impact on fuel consumption. 3D-printing technology can help build lighter fuel-saving aircraft parts, a characteristic essential in an industry that operates at low-profit margins. Additive manufacturing provides advanced manufacturing techniques for developing the components, parts while maintaining the strength and aerodynamic features of an aircraft. This is an important motivating factor for airlines to procure newer generation aircraft, which will drive the growth of the additive-manufacturing sector. The aircraft segment currently holds the major share in 3D printing for the aerospace and defense market.

3D-printing technology also provides companies with a critical competitive advantage as it offers the flexibility to design and test products multiple times and quickly build prototypes, helping companies to cost effectively reduce uncertainties and improve the functionality of their products, thereby accelerating design cycles and reducing time to market.

By making the production process of components faster, cheaper, and simpler, while also enabling the seamless integration of components into a single structure and reducing the need for external joints, fasteners and adhesives, additive manufacturing has attracted interest from major aircraft manufacturers such as Boeing and Airbus B.V. as well as component producers such as Rolls-Royce, Pratt & Whitney and GE Aviation.

However, 3D-printing technology is facing a significant technical hurdle: real-time process monitoring and control. Due to variability in the 3D-printing process, consistent quality of produced parts is not reliably achieved without postproduction inspection, which is time consuming, costly and results in high rejection costs. Since components and parts can currently be inspected only by CT scans and other means, the producer doesn’t know until the end of the process if the finished parts meet design specifications, resulting in lost time and profits as well as the inability to economically scale up production.

Sigma Labs is revolutionizing the traditional quality assurance process with its quality-assurance software that operates in real-time, in process as parts are being formed unlike any other quality-assurance software on the market, Sigma Labs’ PrintRite3D® is a unique third-party validated software that enables real-time monitoring, analysis, feedback and control during the 3D-printing process of precision metal parts. PrintRite3D detects defects during the production process while providing feedback to machine operators allowing corrective actions to be taken, leading to faster production of metal parts with fewer errors and a more uniform product. Users will realize results in decreased downtime and waste while increasing yield and profits for 3D-printing companies.

Compared to its competitors, Sigma Labs’ PrintRite3D provides users with a superior solution. Most other solutions do not offer features such as crucial calibration filters, raw data export, machine-learning-enabled automated anomaly detection, and 3D thermal data visualization. Within the rapidly growing aerospace sector, Sigma Labs has been recognized as a superior solution to the industry’s critical needs and, as such, was selected by the industry-leading producer Airbus earlier this year to deploy its PrintRite3D Rapid Test and Evaluation Program.

With tier-1 clients such as Airbus, Siemens, Pratt & Whitney and Honeywell evaluating the software, Sigma Labs is on a clear path to grow significantly in 2020. The company is uniquely positioned to capture a significant part of the sizable addressable market with its proprietary technology that enables the entire 3D-metal-printing industry to overcome the single most-significant barrier to adoption in serial production.

For more information, visit the company’s website at www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

• Maximizing profit by creating, leveraging products with 10-to-20x profitability margins
• Investors encouraged to review CBD Biotech’s impressive product line, strategic plan for revenue increase.
• Driving growth in new year with growing demand for CBD products

ChineseInvestors.com Inc. (OTCQB: CIIX) is a leading financial-information website for Chinese-speaking investors in the United States and China. CIIX CEO Warren Wang recently discussed the company’s goals and bright outlook for 2020 during a MoneyTV.net interview with Donald Baillargeon (http://ibn.fm/PlWY7).

The new year looks promising for CIIX, Wang stated. Using Chinese language character sets, the company offers investor-education products and services, real-time market commentary, analysis and educational-related services as well as advertising, public-relations-related support services and consultative services to smaller private companies.

In addition to financial services, the company has invested in the growing demand for cannabidiol (CBD)-based nutrition and health products. An IPO of CIIX’s wholly owned foreign enterprise, CBD Biotech, is anticipated early this year (http://ibn.fm/q0Ycx). In his interview, Wang gave an overview of CBD Biotech’s impressive product line, and he urged investors to do likewise in order to grasp the company’s plan to achieve profitability.

CBD Biotech’s major asset is its 40,000 repeat customers, said Wang, who discussed a B2C division of the company whose purpose is to target these consumers through telemarking and social media. The goal is to see how to retain this targeted group and keep these customers coming back. In addition, a separate CBD Biotech B2B division is working to maximize revenue to wholesalers. The two divisions have the same goals: increase sales, lower costs and maximize profitability.

Regarding stock price, Wang pointed out the hard work of employees, the company’s revenue, and the quality of the product line and profit margins as he shared with investors his confidence in the future of CIIX. CBD cosmetics products have a 10-to-20x profit margin, Wang noted, as he explained that the CBD cosmetic product line will be a vital part of driving growth as the company works to lower costs and maximize profitability. The company achieved almost $5 million in revenue during calendar year 2019, Wang said, and he expressed his optimism regarding the upcoming year as well.

In an earlier interview with Baillargeon (http://ibn.fm/iAVOP), Wang emphasized the bright future of the hemp/CBD industry in China, which has four times the market potential of America. CBD Biotech is one of the first companies to enter the industry, solidifying its place as a big player in the future of cannabis in China.

Last year was a successful year for CIIX, and Wang is looking forward to continued profitability and successful in 2020 as the company works toward an even more stable future.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at  http://ibn.fm/CIIX

• HTC Extraction Systems has developed more than a decade’s experience of building revenues from chemical distillation, and is now using that skillset to enter the increasingly popular arena of cannabinoid consumerism
• The company is finalizing the equipping of facilities in western Canada and California as its cannabinoid extract tolling operations grow
• HTC’s most recent financial report celebrated rising revenues, with a year-over-year increase of nearly 200 percent

In the United States, this year’s national elections promise to keep federal cannabis policy in the spotlight as the large majority of Democratic challengers are fine tuning their pro-pot policies and surveys are showing the majority of Americans prefer more sweeping legalization than federal agencies have been willing to pursue under presidential administrations thus far (http://ibn.fm/kvgTU).

Regardless of the elections’ outcomes, it’s clear that cannabinoid producers and cannabinoid products have been gaining ground in terms of public acceptance and legal permissiveness in most areas of the country. Federal legalization in Canada and Mexico is developing a geopolitical bloc for North American cannabinoid advocates.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has turned its proprietary purification technologies to the task of producing profits within the realm of cannabinoids’ ballooning popularity. The Saskatchewan, Canada-based company is completing new facilities on western Canada’s vast farmlands for harvesting ethanol and ethanol-based extracts from hemp for the cannabidiol (CBD) food and pharmaceutical markets, while extending its reach into the United States through a November purchase agreement which granted the company ownership of Kase Farma Inc., a company authorized to work with hemp cultivation, extraction, refining, formulation and distribution in California (http://ibn.fm/HvRVX).

HTC’s third-quarter financial statement noted revenues had grown by nearly 200 percent in year-over-year quarterly returns, from $1.3 million at the close of September 2018 to $3.3 million by September of this year (http://ibn.fm/vYOVo). Year-end financials are pending.

The company is pursuing a “BOOM” business model in which HTC either obtains participating equity ownership in a production chain partner or uses tolling agreements to keep a percentage of the CBD extract it distills for future sales and offtake agreements, including sales to the cannabinoid pharmaceutical market – building, owning, operating and maintaining its own resources.

HTC has developed and improved on its proprietary systems for biomass, gas and liquid extraction over the course of 14 years. Its trademarked Delta Reclaiming System technology is founded in distillation processes that remove ethanol and ethanol-based solvents used in the extraction process, and the company expects to distribute its CBD through its partnership with Purely Canada Foods.

Purely Canada Foods has been a standard bearer for national pride, providing quality-assured branded products to numerous countries in the North American, Asian, European and African markets (http://ibn.fm/r9Mkq). HTC believes its patented Delta Purification System is now the best available environmental reclaiming technology for the clean energy and biomass extraction industries.

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

• SHRG focuses on owning and operating companies that specialize in direct selling
• Two of its main subsidiaries – Elepreneurs LLC and Elevacity LLC – have grown quickly since 2018
• The company expanded into larger facility to accommodate for growth

Sharing Services Global Corporation (OTCQB: SHRG) is a diversified holding company that focuses on direct selling. SHRG owns or operates a variety of companies that sell products directly to consumers or provide services ranging from health and wellness, energy, technology and more. The company supports home-based entrepreneurs with direct-selling programs.

Sharing Services continues to grow an international network of home-based entrepreneurs, known as Elepreneurs. The company strives to empower these Elepreneurs and elevate its customers’ lives through its subsidiaries. One such subsidiary, Elepreneurs LLC, provides both basic and advanced programs for members who sell products via direct selling. Elepreneurs LLC continues to gain new independent sales representatives who are trained, supported and encouraged by the company.

Elevacity Global LLC is a second SHRG subsidiary. Elevacity’s mission is to improve people’s physical and mental health by offering patented nutritional products. Its proprietary products were developed by a team of experienced nutritionists, doctors, chemists, naturopaths, pharmacists and food scientists (http://ibn.fm/bdgZH).

The Elevacity product line is based on a unique combination of four hormones – dopamine, oxytocin, serotonin and endorphins – that are crucial to a person’s well-being and are identified as D.O.S.E. products. The company also offers skin-care products made from natural ingredients that are safe for all skin types as well as the environment. In a time where depression rates among adults are concerning – during 2013-2016, 8.1% of American adults aged 20 and over had depression in a given two-week period – SHRG’s ‘happiness hormones’ are poised to make a difference in the lives of its consumers (http://ibn.fm/svFsf).

Sharing Services Global Corporation works in synergy with its subsidiaries. Offering live seminars and training events, SHRG works to improve the skills and knowledge of its home-based Elepreneurs around the world. In addition to compensation, the company offers reward programs designed to improve the well-being of these entrepreneurs.

Headquartered out of a 10,000-square-foot facility in Plano, Texas, SHRG has planned for future expansion. Customer-service facilities, operations and training rooms, and a video-production suite are currently available onsite with room for growth in each area. In addition, SHRG is looking forward to international expansion. The Elevacity line of products is currently available in the United States, Canada, New Zealand and Australia.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• InsuraGuest is a hotel and vacation rental property insurer that specializes in covering guests’ property and accidental medical needs on a short-term stay event basis
• The Company’s InsurTech software platform and specialty insurance product is available in all 50 states and is expanding into European and Asian markets
• InsuraGuest recently completed the integration of its proprietary InsurTech platform with the Wisp Resort located in Maryland
• Europe’s vacation rental market, in particular, offers a promising opportunity as millions of users seek accommodations each year
• The luxury travel market is expected to grow by a CAGR of nearly 8 percent between 2019 and 2026

As an increasing number of people seek unique culture-immersive holiday experiences or simply an outlet for spending time together with far-flung family members, the luxury travel market is expected to grow with a CAGR of nearly 8 percent between 2019 and 2026, according to research by analysts at Allied Market Research (http://ibn.fm/T2GG1).

The hotel industry, vacation rental investors and independent Airbnb-type homeowners with rooms for let are poised to provide more options than ever to eager but weary travelers. The United States alone has approximately 9 million second homes, with 25% being rented (http://ibn.fm/7LzUJ), representing a huge market potential for short-term rentals accessible online through sites like Airbnb and Vrbo (http://ibn.fm/qGISY). In addition, the U.S. hotel industry recently reported a healthy rise in year-over-year revenue and revenue per available room (RevPAR) during November, according to American Hotel & Lodging Association (AHLA) publication Lodging (http://ibn.fm/8qYDK).

InsuraGuest Inc. is helping to provide these travelers and the venues they visit with peace of mind through a breakout InsurTech product that targets coverage needs that may not be met by traditional traveler’s insurance, medical insurance or homeowner’s insurance. The company’s specialized API connects with the hotel’s or vacation rental’s property management systems, giving it access to millions of properties worldwide.

“We are excited to be expanding our distribution into Europe. The European market is more than twice the size of the US,” InsuraGuest Chairman and CEO Douglas Anderson stated in a September news release (http://ibn.fm/emRym). “Last year there were 2.8 billion hotel nights stayed in Europe compared to 1.1 billion in the US. Additionally, $100 billion was spent on vacation rentals.”

Most recently, InsuraGuest announced adoption of its proprietary InsurTech software by western Maryland’s Wisp Resort®, a four-season ski, golf and mountain recreational destination.

The InsuraGuest™ coverage is purchased by the hotel and provides coverage for covered claims from each registered guest and all room occupants upon check-in. The specialized policies afford coverage to the hotel for hotel liability coverage, which includes in-room damage, loss or stolen goods, accidental medical expense and accidental death and dismemberment benefits up to the policy limits, as underwritten by Crum & Forster companies.

The vacation rental market is increasingly becoming the preferred night-stay option for some travelers and it is enjoying a global scale. Real estate trend watchers at the iPropertyManagement.com website predict vacation rentals will overtake the hotel industry’s revenues this coming year (http://ibn.fm/uLzPm), citing over 150 million Airbnb users worldwide and 60 percent of those accounts in Europe.

An increasing number of insurance providers are offering short-term rental insurance policies to property owners that don’t protect the property’s guests. InsuraGuest’s aim is to fill that gap and cover the guest in case of property liability damage or theft, as well as liability in case guests suffer accidental injuries that require medical attention while on the property.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to InsuraGuest are available in the company’s newsroom at http://ibn.fm/InsuraGuest

• U.S. sales of hemp-based CBD products to reach $22 billion by 2022
• HTC Extraction Systems recently closed $10 million bought deal private placement of units to fund expansion operations
• Company has developed a 19,000-square-foot GMP Euro compliant extraction tolling facility near Regina, Saskatchewan
• Patented technology is designed to reduce CBD waste during extraction process

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) is feeling positive about 2020 based on its unique “local to grower” drying-to-biomass storage capability and transportation of dried biomass to its extraction facilities. In addition, HTC’s patented Delta Purification™ technology recycles, reuses, and purifies the extraction ethanol used in the cannabidiol (CBD) extraction process, being designed to optimally manage and reduce any CBD waste losses by re-extracting all wastes the purified ethanol yields.

A hemp biomass cultivation, extraction, formulation and refining entity, HTC is a force to be reckoned with in the CBD extraction market, as U.S. sales of hemp-based CBD products are projected to reach $22 billion by 2022, up from $591 million in 2018 (http://ibn.fm/1WoCw). CBD derivatives alone are expected to generate $900 million in 2020 (http://ibn.fm/c0sBb). These include CBD-infused topicals, edibles, and vapes.

In this fast-growing market, HTC Extraction Systems is hard at work to expand operations and position itself as a major provider of CBD extraction services, having already deployed extensive investments in the acquisition of extracting, purifying and refining equipment. Recently, HTC closed a bought deal private placement with gross proceeds of $10 million (http://ibn.fm/rnNYH) to finance 25 million units of the company. The proceeds are used to fund the company’s future growth plans.

HTC’s current and new technologies include Delta CBD Reclaiming System™, which reclaims and purifies ethanol for use in CBD biomass extraction and reduces heat to prevent damage of the CBD molecule’s chemical properties. The technology allows the CBD extracted with its help to meet human consumption requirements.

HTC’s Delta Glycol Reclaiming System™ purifies glycols for use in natural gas dehydration processes. These include mono-ethylene glycol and tri-ethylene glycol. The company’s Delta Solvent Reclaiming System reclaims and purifies ethanol-based solvents, such as formulated, mixed, and single amines, for use in post-combustion CO2 capturing processes and natural gas processing.

To further expand operations, HTC acquired California-based Kase Farma Inc., a high-quality, premium hemp goods producer who also provides white-label manufacturing for other cannabinoid suppliers. This company is widely recognized for its firm engagement to customers, community, and the environment (http://ibn.fm/xSbfx).

Among HTC’s strategic initiatives are potential U.S. operations, tolling contracts, marketing and distribution agreements, project construction updates, and extraction equipment purchasing. For the 2020 hemp growing and production year, the company will sign IPGrow™ hemp biomass tolling contracts with producers and with hemp biomass providers in the United States.

Additionally, HTC completed a 19,000-square-foot facility that will house extraction and formulation processing, quality assurance testing, and product development laboratories at its Port Lajord location 17 miles southeast of Regina, Saskatchewan. The facility will be on par with the highest performance and quality standards for extraction and refining worldwide.

The company also finalized the construction of a 27,000-square-foot hemp biomass processing and storage facility, which will be used to store extraction-ready biomass. The company reports major investments in the purchase of extraction, purification, and refining equipment.

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC